DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) saw a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 218,900 shares, an increase of 58.9% from the February 13th total of 137,800 shares. Approximately 0.4% of the company’s shares are sold short. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 2,189.0 days.
DiaSorin Price Performance
OTCMKTS DSRLF remained flat at $109.60 on Friday. DiaSorin has a 1-year low of $100.26 and a 1-year high of $109.60. The company has a fifty day moving average of $104.90 and a 200-day moving average of $103.98.
Wall Street Analyst Weigh In
Separately, UBS Group cut DiaSorin from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 26th.
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Featured Stories
- Five stocks we like better than DiaSorin
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 3 Fintech Stocks With Good 2021 Prospects
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Healthcare Dividend Stocks to Buy
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.